Truist Financial
ABMD

Truist Financial’s Abiomed Inc ABMD Stock Holding History

Truist Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,239
Closed -$2.76M – 2720
2022
Q3 		$2.76M Sell
11,239
-319
-3% -$86.1K 0.01% 1019
2022
Q2 		$2.86M Sell
11,558
-1,022
-8% -$276K 0.01% 1043
2022
Q1 		$4.17M Buy
12,580
+10,597
+534% +$3.26M 0.01% 951
2021
Q4 		$713K Sell
1,983
-524
-21% -$177K ﹤0.01% 1824
2021
Q3 		$816K Buy
2,507
+946
+61% +$320K ﹤0.01% 1722
2021
Q2 		$487K Buy
1,561
+16
+1% +$4.91K ﹤0.01% 2076
2021
Q1 		$492K Sell
1,545
-1,158
-43% -$371K ﹤0.01% 1974
2020
Q4 		$877K Sell
2,703
-10,208
-79% -$2.82M ﹤0.01% 1547
2020
Q3 		$3.58M Buy
12,911
+10,424
+419% +$3M 0.01% 845
2020
Q2 		$602K Buy
2,487
+857
+53% +$172K ﹤0.01% 1529
2020
Q1 		$237K Sell
1,630
-233
-13% -$38.7K ﹤0.01% 2014
2019
Q4 		$319K Buy
+1,863
New +$345K ﹤0.01% 2115

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Truist Financial's ABMD Position: Q4 2022 in Review

Truist Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,239 shares — an estimated $2.76M sold.

Truist Financial first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $4.17M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Truist Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Truist Financial sold 11,239 Abiomed Inc shares in Q4 2022, an estimated $2.76M.
  • Truist Financial first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Truist Financial's Abiomed Inc position peaked at $4.17M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Truist Financial's 13F filing for Q4 2022, filed 17 Feb 2023.